Retinoblastoma fusion polypeptides

Details Retinoblastoma fusion polypeptides Retinoblastoma fusion polypeptides

1997-02-14

2000-06-13

Hutzell, Paula K.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

435 711, 536 234, C12P 2104, C07H 2104

Patent

active

060748508

ABSTRACT:
Fusions of the transcription factor E2F and the retinoblastoma protein RB are provided, along with methods of treatment of hyperproliferative diseases.

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
patent: 5019369 (1991-05-01), Presant et al.
Sellers et al. A Potent Transrepression Domain in the Retinoblastoma Protein Induces a Cell Cycle Arrest When Bound to E2F Sites PNAS (92)11544-48. 1995.
Chang et al. Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active Form of Retinoblastoma Gene Product. Science (267)518-522, 1995.
Nakano et al. Transcriptional Regulatory Elements in the 5' Upstream and First Intron Region of the Human Smooth Muscle (Aortic Type).alpha.-Actin-Encoding Gene. Gene (99)285-289. 1991.
Adams, P.D. et al., "Transcriptional control by E2F," Cancer Biology 6:99-108 (1995).
Adnane, J. et al., "The Retinoblastoma Susceptibility Gene Product Represses Transcription When Directly Bound to the Promoter," J. Biol. Chem. 270(15):8837-8843 (1995).
Antelman, D. et al., "Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110.sup.RB, the retinoblastoma tumor suppressor protein," Oncogene 10:697-704 (1995).
Arteaga, C.L. et al., "Tissue-targeted Antinsense c-fos Retroviral Vector Inhibits Established Breast Cancer Xenografts in Nude Mice," Cancer Research 56:1098-1103 (1996).
Babajko, S. et al., "Interplay of the Liver-Enriched Transacting Factors, DBP and HNF1, in the Transactivation of Human IGFBP-1 Promoter," Biochem. & Biophys. Research Commun. 196(1):480-486 (1993).
Banas, B. et al., "Analysis of the promoter of the human prostatic acid phosphatase gene," Biochim. Biophy. Acta 1217:188-194 (1994).
Beijersbergen, R.L. et al., "E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo," Genes & Devel. 8:2680-2690 (1994).
Bingle, C.D. et al., "Interaction of CCAAT/enhancer-binding protein .alpha. and .beta. with the rat caeruloplasmin gene promoter," Biochem. J. 294:473-479 (1993).
Bookstein, R. et al., "Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene," Science 247:712-715 (1990).
Buck, V. et al., "Molecular and functional characterisation of E2F-5, a new member of the E2F family," Oncogene 11:31-38 (1995).
Clowes, A.W. et al., "Kinetics of Cellular Proliferation after Arterial Injury," Lab. Invest. 49(3) 327-333 (1983).
Cox, G.A. et al., "Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity," Nature 364:725-729 (1993).
Curiel, D.T. et al., "Adenovirus enhancement of transferrin-polylysine-mediated gene delivery," Proc. Natl. Acad. Sci. U.S.A. 88:8850-8854 (1991).
Dalesandro, J. et al., "Gene Therapy for Donor Hearts: Ex vivo Liposome-Mediated Transfection," J. Thoracic and Cardiovascular Surgery 111(2):416-422 (1996).
Dobrowolski, S.F. et al., "An E2F dominant negative mutant blocks E1A induced cell cycle progression," Oncogene 9:2605-2612 (1994).
Dowdy, S.F. et al., "Physical Interaction of the Retinoblastoma Protein with Human D Cyclins," Cell 73:499-511 (1993).
Dusetti, N.J. et al., "Structural Organization of the Gene Encoding the Rat Pancreatitis-associated Protein," J. Biol. Chem. 268(19):14470-14475 (1993).
Eisenberger, C.L. et al., "Differential Regulation of the Rat Phosphoenolpyruvate Carboxykinase Gene Expression in Several Tissues of Transgene Mice," Mol. Cell Biol. 12(3):1396-1403 (1992).
Fontaine, R.N. et al., "Structure of the Rat Pancreatic Cholesterol Esterase Gene," Biochemistry 30:7008-7014 (1991).
Forss-Petter, S. et al., "Transgenic Mice Expressing .beta.-Galactosidase in Mature Neurons under Neuron-Specific Enolase Promoter Control," Neuron 5:187-197 (1990).
French, B.A. et al., "Percutaneous Transluminal In Vivo Gene Transfer by Recombinant Adenovirus in Normal Porcine Coronary Arteries, Atherosclerotic Arteries, and Two Models of Coronary Restenosis," Circulation 90(5):2402-2413 (1994).
Friedman, J.M. et al., "Cellular Promoters Incorporated into the Adenovirus Genome: Cell Specificity of Albumin and Immunoglobin Expression," Mol. Cell Biol. 6(11):3791-3797 (1986).
Ginsberg, D. et al., "E2F-4, a new member of the E2F transcription factor family, interacts with p107," Genes & Devel. 8:2665-2679 (1994).
Gorman, C.M. et al., "Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells," Mol. Cell Biol. 2(9):1044-1051 (1982).
Hanson, R.D. et al., "The 5'-Flanking Region of the Human CGL-1/Granzyme B Gene Targets Expression of a REporter Gene to Activated T-lymphocytes in Transgenic Mice," J. Biol. Chem. 266(36):24433-24438 (1991).
Hatzoglou, M. et al., "Hepatic Gene Transfer in Animals Using REtroviruses Containing the Promoter from the Gene for Phosphoenolpyruvate Carboxykinase," J. Biol. Chem. 265(28):17285-17293 (1990).
Helftenbein, G. et al., "Expression of the Uteroglobin Promoter in Epithelial Cell Lines from Endometrium," Annals New York Acad. Sci. Bulletti C. et al., eds., New York Academy of Sciences, New York, 622:69-79 (1991).
Hemstrom, C. et al., "Gene Product of Region E4 of Adenovirus Type 5 Modulates Accumulation of Certain Viral Polypeptides," J. Virol. 62(9):3258-3264 (1988).
Hiebert, S.W., "Regions of the Retinoblastoma Gene product Required for Its Interaction with the E2F Transcription Factor Are Necessary for E2 Promoter Repression and pRb-Mediated Growth Suppression," Mol. Cell Biol. 13(6):3384-3391 (1993).
Houchins, J.P. et al., "Genomic structure of nkg5, a human NK and T cell-specific activation gene," Immunogenetics 37:102-107 (1993).
Houglum, K. et al., "LAP (NF-IL6) Transactivates the Collagen .alpha..sub.1 (I) Gene from a 5' Regulatory Region," J. Clin. Invest. 94:808-814 (1994).
Huang, S. et al., "A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product," Nature 350:160-162 (1991).
Huber, B.E. et al., "Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy," Proc. Natl. Acad. Sci. U.S.A., 88:8039-8043 (1991).
Ilantzis, C. et al., "Identification of a Human cancer Related Organ-Specific Neoantigen," Microbiol. Immunol. 37(2):119-128 (1993).
Ivey-Hoyle, M. et al., "Cloning and Characterization of E2F-2, a Novel Protein with the Biochemical Properties of Transcription Factor E2F," Mol. Cell Biol. 13(12):7802-7812 (1993).
Jahroudi, N. et al., "Endothelial-Cell-Specific Regulation of van Willebrand Factor Gene Expression," Mol. Cell. Biol. 14(2):999-1008 (1994).
Kaspar, F. et al., "Characterization of Two Point Mutations in the Androgen REceptor Gene of Patients with Perineoscrotal Hypospadia," J. Steroid Biochem. Molec. Biol. 47(1-6):127-135 (1993).
Kaye, F.J. et al., "A single-amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding," Proc. Natl. Acad. Sci. U.S.A. 87:6922-6926 (1990).
Keller, S.A. et al., "Regulation of amylase gene expression in diabetic mice is mediated by a cis-acting upstream element close to the pancreas-specific enhancer," Genes & Devel. 4:1316-1321 (1990).
Koc, O.N. et al., "Transfer of Drug Resistance Genes Into Hematopoietic Progenitors to Improve Chemotherapy Tolerance," Seminars in Oncology 23(1):46-65 (1996).
Krek, W. et al., "Negative REgulation of the Growth-Promoting Transcription Factor E2F-1 by a Stably Bound Cyclin A-Dependent Protein Kinase," Cell 78:161-172 (1994).
Krek, W. et al., "Cyclin A-Kinase Regulation of E2F-1 DNA Binding Function Underlies Suppression of an S Phase Checkpoint," Cell 83:1149-1158 (1995).
Kruse, F. et al., "An endocrine-specific element is an integral component of an exocrine-specific pancreatic enhancer," Genes & Devel. 7:774-786 (1993).
Lake, R.A. et al., "A 3' transcriptional enhancer regulates tissue-specific expression of the human CD2 gene," EMBO J. 9(10):3129-3136 (1990).
Lee, W.H. et al., "The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DN

Affiliated with

Also associated with

Rating

Retinoblastoma fusion polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retinoblastoma fusion polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoblastoma fusion polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2067537